Navigation Links
Vitrasert Sterile Intraviteral Implant

ProductsVitrasert Sterile Intraviteral Implant
Company Bausch & Lomb Storz
Item Vitrasert Sterile Intraviteral Implant
Features The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months. Implantation normally takes less than one hour, requires only local anesthesia, and is conducted in an outpatient, day-surgery setting. Immediately following insertion of the implant, most patients experience transient blurred vision in the operated eye, which generally clears within two to four weeks. The implant can be removed when depleted of drugs, usually within five to eight months, and a new Vitrasert implant can be inserted.
Description Vitrasert implant is a device that delivers ganciclovir intraocularly in patients with Aids-related Cytomegalovirus (CMV) Retinitis. This approach can significantly delay progression of CMV when compared with conventional intravenous treatment. The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Sterile Blades
2. Sterile Cordless Eraser Tips
3. Sensitive Eyes Sterile Saline Spray
4. Sterile Preserved Saline Solution
5. Lens Plus Sterile Saline Solution
6. Sterile Preserved Daily Cleaner
7. Non-Sterile Oncoseed (Iodine-125 Seeds)
8. Oncoseed Sterile Convenience Pack (Iodine-125 Seeds)
9. Balanced Salt Solution (Sterile Irrigating Solution)
10. Hoffmann Classic Sterile Wrist Kit
11. Biotrace Sterile Barium Sulfate USP
... isotopic anemia assays feature ... ,pipetting steps for greater ... the processes ,involved in ... benefit to your laboratory ...
... Scientific, Inc. ANA Screen ELISA test system is ... antibodies (ANA) in human sera. When performed according ... capable of detecting all ANAs commonly tested for, ... Jo-1, Sm, Sm/RNP, SSA, SSB, and Scl-70. The ...
... ANA uses a patented HEp-2 cell line ... the sensitivity to SS-A/Ro autoantibodies, without affecting ... studies have been published worldwide on the ... to SS-A/Ro autoantibodies when used in place ...
... ENA assays can be used to ... antibodies, which are associated with various ... lupus erythematosus (Lupus), Sjgren's syndrome, mixed ... scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. ...
Medicine Products:
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Cancer Care.” , The print component of “Revolutionizing Cancer Care” is ... New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 copies ...
(Date:2/12/2016)... ... February 12, 2016 , ... US Sport Camps is pleased to announce ... located in Norwalk, serves as the host site and directing the camps is PGA ... have had successful camps in recent years around Des Moines and are fortunate to ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... explosive growth in the field of long term care. With that, says Patrick ... well-trained healthcare professionals in administrative roles in long term care environments. His company, ...
(Date:2/12/2016)... ... ... of restorative dentistry, to date there has been no other option in the U.S. to ... is a now a new protocol in stopping cavity progression; Silver Diamine Fluoride (SDF). ... The application is as simple as drying the tooth and applying the SDF to ...
(Date:2/11/2016)... CA (PRWEB) , ... February 11, 2016 , ... According ... System, a product marketed as a weight loss dietary supplement, is being recalled due ... group Beverly Hills Physicians, because there is not a single supplement on the market ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12. Februar 2016  Sequent Medical, Inc. gab ... Patienten für eine Studie zur Sicherheit und Wirksamkeit ... für die Behandlung von rupturierten intrakraniellen Aneurysmen begonnen ... der Neuroradiologie an der Universitätsklinik Bicètre in ... CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, ... Inc. today announced they will form a partnership ... precision medicine in cancer. The goal of the ... technology with Macrogen,s high-throughput Next Generation Sequencing capabilities ... Clinical Laboratory Improvement Amendments (CLIA) of 1988 by ...
(Date:2/12/2016)... 12 februari 2016 AAIPharma Services ... leverancier van productie en ontwikkeling op maat ... vandaag een uitbreiding aan van steriele vul- ... in Charleston, SC . ... meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
Breaking Medicine Technology: